| Name | Title | Contact Details |
|---|
Proudly serving the community since 1952, Tahoe Forest Hospital is a not for profit rural health care facility and designated Critical Access Hospital. It is fully accredited by the Healthcare Facilities Accreditation Program and licensed by the State of California Department of Health Services. Tahoe Forest Hospital has 25 acute care beds and 36 long-term care beds. Our geographic area covers six rural counties, two states and approximately 3,500 square miles with primary services reaching the communities of Truckee, North Lake Tahoe, Donner Summit and the Sierra Valley in California and Incline Village in Nevada. Tahoe Forest Hospital serves a full-time population of approximately 40,000 residents with influxes of up to an additional 30,000 tourists during peak periods.
StemCells, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery primarily in the United States. Its lead therapeutic product candidate, HuCNS-SC cells (purified human neural stem cells), is in development as a potential treatment for a range of central nervous system disorders. The company has conducted a Phase I clinical trial in Pelizaeus-Merzbacher disease, a fatal myelination disorder in children. It is also conducting a Phase I/II clinical trial in chronic spinal cord injury; and has initiated a Phase I/II clinical trial in dry age-related macular degeneration, as well as is pursuing preclinical studies in Alzheimer’s disease. In addition, the company markets a rage of proprietary cell culture products, research grade human cells, and antibody reagents under the SC Proven brand. The proprietary cell culture products include iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff227, NDiff N2, and NDiff N27 supplements, as well as HEScGRO and ESGRO Complete; and antibody reagents comprise STEM24, STEM101, STEM121, and STEM123, which can be used for cell detection, isolation, and characterization. Further, StemCells is involved in developing and commercializing applications of its technologies to enable stem cell-based research. The company sells its tools and technologies products to researchers at academic institutions, pharmaceutical and biotechnology companies, and government laboratories. StemCells, Inc. was founded in 1988 and is headquartered in Newark, California.
Cure Alzheimers Fund is a non-profit organization that funds targeted research with the highest probability of preventing, slowing, or reversing Alzheimers disease.
MedeAnalytics provides evidence-based insights to solve a real problem that plagues health care – how to use the immense amount of patient data collected along the care continuum to deliver cost – effective care and promote a healthier population. The platform delivers intelligence that helps healthcare organizations detect their greatest areas of risk and identify opportunities to improve their financial health. It empowers providers and health plans to collaborate and use data to strengthen their operations and improve the quality of care. MedeAnalytics` cloud-based tools have been used to analyze more than 21 billion patient encounters in the United States and United Kingdom, providing better care to more than 30 million patients and better business for 900 healthcare organizations.
Hugh Chatham Memorial Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Hugh Chatham Memorial Hospital is based in Elkin, NC. You can find more information on Hugh Chatham Memorial Hospital at www.hughchatham.org